EMEA-001729-PIP01-14-M01

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Recombinant human nerve growth factor

Decision numberP/0280/2016
PIP numberEMEA-001729-PIP01-14-M01
Pharmaceutical form(s)Eye drops, solution
Condition(s)/indication(s)

Treatment of neurotrophic keratitis

Route(s) of administrationOcular use
PIP applicant

Dompé farmaceutici SpA
Italy
Tel.: +39 3669018586
Email: lamberto.dionigi@dompe.com

Decision typePM: decision on the application for modification of an agreed PIP
Compliance check procedure numberEMEA-C-001729-PIP01-14-M01
Compliance check opinion date10/11/2017
Compliance check outcomePositive

Decision